← Back to front page
United States · Platforms & data · MarketBeat

What Alpha Cognition (ACOG) Said on Its Q3 Earnings Call

Published by MarketBeat · United States 1 h ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Alpha Cognition (NASDAQ:ACOG) reported third-quarter 2026 net product revenue of approximately $7.8 million, up 30% from the preceding quarter, as prescriptions and prescriber adoption increased for its Alzheimer’s treatment ZUNVEYL. Management reiterated its goal of reaching operating profitabilit

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Dell Technologies vs. Taiwan Semiconductor: Which Technology Stock Is a Better Buy for 2027?

 MarketWatch

Your holiday credit-card bills are going up. What you can do to ease the pain.

 Seeking Alpha

Here are the major earnings before the open Thursday

 CNBC

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

 Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

 TipRanks

Cogna approves buyback program for up to 141,792,187 common shares